Literature DB >> 19484457

Treating refractory scleritis with infliximab.

Seong Joon Ahn, Joo Youn Oh, Mee Kum Kim, Won Ryang Wee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19484457     DOI： 10.1007/s10384-008-0652-5

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN： 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  4 in total

Review 1.  Biologic agents in the management of inflammatory eye diseases.

Authors:  Kira Michalova; Lyndell Lim
Journal:  Curr Allergy Asthma Rep       Date:  2008-07       Impact factor: 4.806

2.  Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease.

Authors:  J R Smith; R D Levinson; G N Holland; D A Jabs; M R Robinson; S M Whitcup; J T Rosenbaum
Journal:  Arthritis Rheum       Date:  2001-06

3.  Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.

Authors:  Anat Galor; Victor L Perez; Jeffrey P Hammel; Careen Y Lowder
Journal:  Ophthalmology       Date:  2006-09-25       Impact factor: 12.079

4.  Infliximab therapy for the treatment of refractory ocular inflammatory disease.

Authors:  Lucia Sobrin; Eva C Kim; William Christen; Thekla Papadaki; Erik Letko; C Stephen Foster
Journal:  Arch Ophthalmol       Date:  2007-07
  4 in total
  4 in total

Review 1.  Biologic therapy for refractory scleritis: a new treatment perspective.

Authors:  Tania Sales de Alencar de Fidelix; Luis Antonio Vieira; Denise de Freitas; Virginia Fernandes Moça Trevisani
Journal:  Int Ophthalmol       Date:  2015-08-29       Impact factor: 2.031

2.  Successful treatment of severe nodular scleritis with adalimumab.

Authors:  Juan P Restrepo; María P Molina
Journal:  Clin Rheumatol       Date:  2010-02-14       Impact factor: 2.980

Review 3.  Pharmacotherapy of scleritis: current paradigms and future directions.

Authors:  Robert M Beardsley; Eric B Suhler; James T Rosenbaum; Phoebe Lin
Journal:  Expert Opin Pharmacother       Date:  2013-02-21       Impact factor: 3.889

Review 4.  Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review.

Authors:  Jurgen Sota; Matteo-Maria Girolamo; Bruno Frediani; Gian Marco Tosi; Luca Cantarini; Claudia Fabiani
Journal:  Ophthalmol Ther       Date:  2021-09-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.